Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALAGet Free Report) in a report issued on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of NASDAQ CALA opened at $0.02 on Friday. The company’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.02. Calithera Biosciences has a 52 week low of $0.00 and a 52 week high of $0.13.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

See Also

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.